Testing effectiveness (Phase 2)Study completedNCT03866967What this trial is testingAnti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Akeso 130
Not applicableUnknownNCT06335147What this trial is testingPD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon CancerWho this might be right forMetastatic Colon Cancer Henan Cancer Hospital 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317What this trial is testingPD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After SurgeryWho this might be right forIntrahepatic Cholangiocarcinoma Shanghai Zhongshan Hospital 65
Post-approval studies (Phase 4)UnknownNCT04040491What this trial is testingPD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Mingzhi Zhang 100
Testing effectiveness (Phase 2)UnknownNCT03972722What this trial is testingStudy of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Guangzhou Gloria Biosciences Co., Ltd. 89
Early research (Phase 1)Study completedNCT03547037What this trial is testingEvaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid CancersWho this might be right forNeoplasm Janssen Pharmaceutical K.K. 22
Not applicableNot Yet RecruitingNCT06682247What this trial is testingA Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal CancerWho this might be right forColorectal Cancer Metastatic Feng Wang 200
Testing effectiveness (Phase 2)Looking for participantsNCT06635785What this trial is testingSafety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor OncoC4, Inc. 204
Testing effectiveness (Phase 2)Looking for participantsNCT06981325What this trial is testingEvaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) PatientsWho this might be right forBasal Cell Carcinoma (BCC)First Line Treatment Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 34
Early research (Phase 1)UnknownNCT03468751What this trial is testingPhase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Henlix, Inc 30
Not applicableActive Not RecruitingNCT06796231What this trial is testingEfficacy of PD-1 Monoclonal Antibody in the Treatment of PhaeohyphomycosisWho this might be right forPhaeohyphomycosis Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Testing effectiveness (Phase 2)UnknownNCT04367025What this trial is testingEfficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric CancerWho this might be right forGastric Cancer Chinese PLA General Hospital 70
Testing effectiveness (Phase 2)UnknownNCT03250962What this trial is testingSHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin LymphomaWho this might be right forHodgkin Lymphoma Chinese PLA General Hospital 280
Testing effectiveness (Phase 2)Ended earlyNCT03645876What this trial is testingSHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06394791What this trial is testingEvaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute ObstructionWho this might be right forLeft-sided Colorectal Cancer Complicating Acute Obstruction The First Affiliated Hospital with Nanjing Medical University 27
Testing effectiveness (Phase 2)UnknownNCT04014101What this trial is testingSHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04444167What this trial is testingAnti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Akeso 59
Not applicableNot Yet RecruitingNCT06155422What this trial is testingA Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forRecurrent or Metastatic Cervical Cancer Gang Chen (101199) 670
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05982522What this trial is testingIN10018 Combination Therapy in Previously-treated Solid TumorsWho this might be right forSolid Tumor InxMed (Shanghai) Co., Ltd. 72
Early research (Phase 1)WithdrawnNCT04799431What this trial is testingNeoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerWho this might be right forPancreatic Cancer MetastaticColorectal Cancer Metastatic Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins